Prosthetic Heart Valve Market | Industry Report 2017 – 2022
According to the new market research report Prosthetic Heart Valve Market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9% during the forecast period.
The key factors driving the growth of this market include the rising
geriatric population and the subsequent growth in the prevalence of HVD,
regulatory approvals for new and advanced prosthetic...
Prosthetic Heart Valve Market : Industry Analysis, Growth, Size, End User and – Global Forecast 2022
The global prosthetic heart valves market is expected to reach USD 8,862.9 million by 2022.
Factors such as rising geriatric population, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about heart valve diseases, and favourable reimbursement scenario for prosthetic heart valves are driving the growth of the...
Prosthetic Heart Valve Market : Top Key players and Objectives – Global Forecast to 2022
Top Key Players :
The key players in the Prosthetic heart valve market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve,...